Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Doctor At Center Of Medtronic Meal Kickback Scheme To Pay $4.4M Settlement

Executive Summary

The settlement resolves allegations the neurosurgeon collected kickbacks both for using Medtronic devices and for buying devices through his own distributorships.

You may also be interested in...



Medtronic Pays $9.2M To Resolve False Claims Beef

The payments violated both the False Claims Act and the Open Payments Program, the government says.

Sprinting To Approval: Insider Tips On FDA’s Breakthrough Devices Program

Manufacturers applying to the program should be ready for questions from the US agency, an FDA official says.

Device Week, 7 May 2021 – New MDUFA, Old Disagreements

In this week’s podcast, senior reporter Ferdous Al-Faruque gives an early look at how user fee negotiations between the US FDA and industry groups for MDUFA V are unfolding. As in the past, the parties are at odds over how much industry should pay, and what the FDA is using the money for.

Topics

UsernamePublicRestriction

Register

MT143881

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel